Title: Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma.
Journal: Cancer cell 20170109
1620401-83-3
1481677-78-4
864289-85-0
2328073-61-4
1784252-84-1
89151-35-9
1622840-55-4 | 1(2H)-Pyridinecarboxylic acid, 5-bromo-3,4-dihydro-, 1,1-dimethylethyl ester | AA001SVG | MFCD28054690
16264-08-7 | 1-Acetyl-4-(4-nitrophenyl)piperazine | AA001T7O | MFCD00248261
163042-96-4 | 2-Cl-ib-meca | AA001TK8 | MFCD01861178
1632286-11-3 | 5-Bromo-2-(piperidin-3-yloxy)pyrimidine hydrochloride | AA001TU1 | MFCD28144976
16355-28-5 | Pregn-4-ene-3,11,20-trione, 6,17,21-trihydroxy-, (6β)- | AA001U59 | MFCD00057669
1638761-24-6 | tert-Butyl n-(2-azaspiro[3.4]octan-6-yl)carbamate | AA001UEM | MFCD27986988
164331-38-8 | tert-Butyl 4-methanesulfonylpiperazine-1-carboxylate | AA001UQ5 | MFCD03942726
164736-47-4 | 7-Bromo-1,2,3,4-tetrahydrocyclopenta[b]indole | AA001V0D | MFCD00239009
1609396-24-8 | 2-(Chloromethyl)isonicotinonitrile hydrochloride | AA001VFB | MFCD28024788
16162-28-0 | Benzo[1,2-d:4,5-d']bis(thiazole)-2,6-diamine | AA001VO5 | MFCD00465256